These findings are consistent with new genetic linkages with the Reelin signaling pathway in AD pathogenesis (Bracher-Smith et al., 2022, Lopera et al., 2023), pointing to a likely underlying mechanism of Apoer2 regulation of the Reelin signaling pathway in AD. The gene discussed is RELN; the disease is Alzheimer disease.